近日，聚焦人工智能与医学诊断的深度融合的AI生物医学初创公司深圳市瑞图生物技术有限公司宣布成功完成超亿元B2轮融资。本轮融资由国科投资、国内知名基金领投，深投控资本参与投资，点石资本担任独家财务顾问。
据悉，瑞图生物是一家专注于AI生物医学领域的初创公司，致力于将人工智能技术与医学诊断相结合，为患者提供更加准确、快速的诊断服务。此次融资将用于公司研发团队的建设和产品线的拓展，以及市场推广等方面。
国科投资表示，瑞图生物在AI生物医学领域具有较强的技术实力和创新能力，其产品在临床上已经取得了一定的成果。未来，国科投资将继续支持瑞图生物的发展，共同推动AI技术在医学领域的应用。
深投控资本则表示，瑞图生物作为一家专注于AI生物医学领域的初创公司，具有很大的发展潜力。深投控资本将积极参与瑞图生物的后续融资活动，并为其提供全方位的支持和服务。
点石资本作为瑞图生物的独家财务顾问，将为公司提供专业的财务咨询和管理服务，助力瑞图生物实现更好的发展。
英语如下：
Title: Ruitu Biotech Completes Over 100 Million Yuan B2 Round Financing and Accelerates Innovation in AI Medical Diagnosis Field
Keywords: Ruitu Biotech, B2 round financing, artificial intelligence
News content: Recently, Ruitu Biotech Technology Co., Ltd., an AI biomedicine startup focusing on the deep integration of artificial intelligence and medical diagnosis, announced the successful completion of over 100 million yuan in B2 round financing. This round of financing was led by Guoke Investment and well-known domestic funds, with Shenzhen Investment Holding Capital participating in investment and Dianshi Capital serving as the exclusive financial adviser.
It is reported that Ruitu Biotech is a start-up company specializing in the field of AI biomedicine, committed to combining artificial intelligence technology with medical diagnosis to provide more accurate and rapid diagnosis services for patients. The financing will be used for the construction of the company’s research and development team, the expansion of its product line, and market promotion.
Guoke Investment stated that Ruitu Biotech has strong technical strength and innovation ability in the field of AI biomedicine, and its products have achieved certain results in clinical practice. In the future, Guoke Investment will continue to support Ruitu Biotech’s development and jointly promote the application of AI technology in the medical field.
Shenzhen Investment Holding Capital expressed that Ruitu Biotech, as a startup company focusing on AI biomedicine, has great potential for development. Shenzhen Investment Holding Capital will actively participate in Ruitu Biotech’s subsequent financing activities and provide comprehensive support and services for it.
Dianshi Capital, as Ruitu Biotech’s exclusive financial adviser, will provide professional financial consulting and management services to help Ruitu Biotech achieve better development.
【来源】https://www.vbdata.cn/1518942969
Views: 1